GALANIN-(1-15), BUT NOT GALANIN-(1-29), MODULATES 5-HT1A RECEPTORS IN THE DORSAL HIPPOCAMPUS OF THE RAT-BRAIN - POSSIBLE EXISTENCE OF GALANIN RECEPTOR SUBTYPES

被引:59
作者
HEDLUND, PB [1 ]
FINNMAN, UB [1 ]
YANAIHARA, N [1 ]
FUXE, K [1 ]
机构
[1] UNIV SHIZUOKA,SCH PHARMACEUT SCI,BIOORGAN CHEM LAB,SHIZUOKA 422,JAPAN
关键词
GALANIN; GALANIN FRAGMENT; 5-HYDROXYTRYPTAMINE; RECEPTOR INTERACTION; RECEPTOR SUBTYPE; BRAIN;
D O I
10.1016/0006-8993(94)90271-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aim of the present study was to evaluate whether galanin-(1-29) and galanin-(1-15) can modulate the 5-hydroxytryptamine(1A) (5-HT1A) receptors using [H-3]8-OH-2-(di-n-propylamino)-tetralin ([H-3]8-OH-DPAT) as a radioligand. Membrane preparations of the dorsal hippocampus, an area having the recently described [I-125]galanin-(1-15) fragment binding sites, but having very few porcine [I-125]galanin-(1-29) binding sites, were used. Galanin-(1-15) produced a concentration-dependent increase in the K-d value of [H-3]8-OH-DPAT with a maximum effect of approximately 65% at 3 nM of galanin-(1-15), whereas galanin-(1-29) had no effect. This increase of the K-d value of [H-3]8-OH-DPAT could be completely counteracted by the putative galanin antagonist M35 (1 nM). The B-max values of [H-3]8-OH-DPAT were not affected in any experiment. In conclusion, the present results give further evidence for the existence of a galanin receptor subtype mainly recognizing N-terminal galanin fragments, also having the ability to reduce the affinity of 5-HT1A receptors.
引用
收藏
页码:163 / 167
页数:5
相关论文
共 21 条
[1]   GALANIN AND GALANIN ANTAGONISTS - MOLECULAR AND BIOCHEMICAL PERSPECTIVES [J].
BARTFAI, T ;
FISONE, G ;
LANGEL, U .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (08) :312-317
[2]  
Cochran W.G, 1957, STAT METHODS, V6th ed
[3]   HUMAN GALANIN - MOLECULAR-CLONING REVEALS A UNIQUE STRUCTURE [J].
EVANS, HF ;
SHINE, J .
ENDOCRINOLOGY, 1991, 129 (03) :1682-1684
[4]   N-TERMINAL GALANIN-(1-16) FRAGMENT IS AN AGONIST AT THE HIPPOCAMPAL GALANIN RECEPTOR [J].
FISONE, G ;
BERTHOLD, M ;
BEDECS, K ;
UNDEN, A ;
BARTFAI, T ;
BERTORELLI, R ;
CONSOLO, S ;
CRAWLEY, J ;
MARTIN, B ;
NILSSON, S ;
HOKFELT, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) :9588-9591
[5]   GALANIN SELECTIVELY MODULATES 5-HYDROXYTRYPTAMINE 1A RECEPTORS IN THE RAT VENTRAL LIMBIC CORTEX [J].
FUXE, K ;
VONEULER, G ;
AGNATI, LF ;
OGREN, SO .
NEUROSCIENCE LETTERS, 1988, 85 (01) :163-167
[6]   INTRAVENTRICULAR-INJECTIONS OF GALANIN REDUCES 5-HT METABOLISM IN THE VENTRAL LIMBIC CORTEX, THE HIPPOCAMPAL-FORMATION AND THE FRONTO-PARIETAL CORTEX OF THE MALE-RAT [J].
FUXE, K ;
OGREN, SO ;
JANSSON, A ;
CINTRA, A ;
HARFSTRAND, A ;
AGNATI, LF .
ACTA PHYSIOLOGICA SCANDINAVICA, 1988, 133 (04) :579-581
[7]   ACTIVATION OF 5-HYDROXYTRYPTAMINE-1A RECEPTORS INCREASES THE AFFINITY OF GALANIN RECEPTORS IN DIENCEPHALIC AND TELENCEPHALIC AREAS OF THE RAT [J].
HEDLUND, P ;
VONEULER, G ;
FUXE, K .
BRAIN RESEARCH, 1991, 560 (1-2) :251-259
[8]   EVIDENCE FOR SPECIFIC N-TERMINAL GALANIN FRAGMENT BINDING-SITES IN THE RAT-BRAIN [J].
HEDLUND, PB ;
YANAIHARA, N ;
FUXE, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 224 (2-3) :203-205
[9]   CENTRALLY COINJECTED GALANIN AND A 5-HT1A AGONIST ACT SYNERGISTICALLY TO PRODUCE VASODEPRESSOR RESPONSES IN THE RAT [J].
HEDLUND, PB ;
AGUIRRE, JA ;
NARVAEZ, JA ;
FUXE, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 204 (01) :87-95
[10]  
HOKFELT T, 1991, GALANIN NEW MULTIFUN